Page 31 - Genentech News Today

On Feb. 16, 2024, the Food and Drug Administration approved the drug Xolair for those with severe food allergies to prevent severe reactions.

Xolair, or omalizumab, was approved by the FDA to help reduce severe allergic reactions to certain foods in adults and children over the age of one, including reducing the risk of anaphylaxis that may occur with accidental exposure.

Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.

A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday.

Xolair, which is developed and co-promoted by Genentech and Novartis in the US, was originally approved in 2003 for the treatment of moderate to severe persistent allergic asthma in certain

Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.

The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple

A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug …

A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions.

A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions.